Advertisement

Pharmacy World and Science

, Volume 26, Issue 3, pp 143–147 | Cite as

Reasons for polypharmacy among psychiatric patients

  • Réka Viola
  • Katalin Csukonyi
  • Péter Doró
  • Zoltán Janka
  • Gyöngyvér Soós
Article

Abstract

Introduction: Increasing attention has recently been focused on polypharmacy, which is often referred to as an indicator of irrational drug consumption. Although polypharmacy is an important risk factor for problems arising from drug therapies, certain health concerns and conditions or patient-specific factors may justify the need for polypharmacy. In recent years there no data have been published regarding polypharmacy in Hungary.

Objective: The authors examined the frequency of polypharmacy among psychiatric patients. The study also looked at the extent to which comorbidity and demographic characteristics (age, gender) were responsible for the multiple drug use.

Methods: An inpatient database of the year 2001 at the psychiatric department was analysed. Based on the standard definition of polypharmacy the authors enrolled into the polypharmacy group those patients who were on more than five drugs as part of chronic and simultaneous therapy. The data were analysed with the SPSS 9.0 statistics program package.

Results: Among the psychiatric patients included in the study (N=984) the frequency of polypharmacy was 33.6%. Significant correlation was found between the investigated factors (age, gender, comorbidity) and polypharmacy. On the basis of OR-values, comorbidity was the strongest inducer of polypharmacy.

Conclusion: Polypharmacy cannot be fundamentally regarded as unnecessary drug use. Numerous facts prove that in certain diseases and conditions adequate polypharmacy is necessary.

Comorbidity Drug use Hungary Polypharmacy Psychiatry Psychiatric patients 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lee RD. Polypharmacy: a case report and new protocol for management. J Am Board Fam Pract 1998; 11: 140–4.Google Scholar
  2. 2.
    Viktil KK, Enstand M, Kutschera J. Polypharmacy among patients admitted to hospital with rheumatic diseases. Pharm World Sci 2001; 23: 153–8.Google Scholar
  3. 3.
    Thomas HF, Sweetnam PM, Janchawee B, Luscombe DK. Polypharmacy among older men in South Wales. Eur J Clin Pharmacol 1999; 55: 411–5.Google Scholar
  4. 4.
    Veehof LJG, Stewarde RE, Meyboom-de jong B, Haaqijer-Ruskamp FM. Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Parmacol 1999; 55: 533–6.Google Scholar
  5. 5.
    Bjerrum L, Sogaard J, Hallas J, Kragstrup J. Polypharmacy: correlations with sex, age and drug regimen. Eur J Clin Pharmacol 1998; 54: 197–202.Google Scholar
  6. 6.
    Bjerrum L, Rosholm JU, Hallas J, Kragstrup J. Methods for estimating the occurence of polypharmacy by means of prescription database. Eur J Clin Pharmacol 1997; 53: 7–11.Google Scholar
  7. 7.
    Carlson JE. Perils of polypharmacy: 10 steps to prudent prescribing. Geriatrics 1996; 51(7): 26–30, 35.Google Scholar
  8. 8.
    Steward RB, Yedinak KC, Ware MR. Polypharmacy in psychiatry: three case studies and methods for prevention. Ann Pharmacother 1992; 26: 529–33.Google Scholar
  9. 9.
    Colley CA, Lucas LM. Polypharmacy: the cure becomes the disease. J Gen Intern Med 1993; 8(5): 278–83.Google Scholar
  10. 10.
    Rittmannsberg H. The use of drug monotherapy in psychiatric inpatient treatment. Prog Neuro-Psychopharmacol Biol Psychiatry 2002; 26: 547–51.Google Scholar
  11. 11.
    Nobili A, Tettamanti M, Frattura L, Spagnoli A, Ferraro L. Drug use by elderly in Italy. Ann Pharmacother 1997; 31: 416–22.Google Scholar
  12. 12.
    Jörgensen TM, Isacson DGL, Thorslund M. Prescription drug use among ambulatory elderly in a Swedish municipality. Ann Pharmacotherapy 1993; 27: 1120–5.Google Scholar
  13. 13.
    Kennerfalk A, Ruigómez A, Wallander MA, Wilhelmsen L, Johansson S. Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 2002; 36: 797–803.Google Scholar
  14. 14.
    Jörgensen T, Johansson S, Kennerfalk A, Wallander MA, Svardsudd K. Prescription drug use, diagnoses and healthcare utilization among the elderly. Ann Pharmacotherapy 2001; 35: 1004–9.Google Scholar
  15. 15.
    van Dijk KN, de Vries CS, van den Berg PB, Brouwers JRB, de Jong-van den Berg LTW. Drug utilisation in Dutch nursing homes. Eur J Clin Pharmacol 2000; 55: 765–71.Google Scholar
  16. 16.
    Health Statistic Unit of the Health Promotion Research Institute: National Health Survey, Hungary, 2000.Google Scholar
  17. 17.
    Soós Gy, Viola R, Csukonyi K. Polypharmacy is certainly inappropriate? 30th European Symposium on Clinical Pharmacy, 2001.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Réka Viola
    • 1
  • Katalin Csukonyi
    • 2
  • Péter Doró
    • 1
  • Zoltán Janka
    • 2
  • Gyöngyvér Soós
    • 1
  1. 1.University of Szeged, Faculty of Pharmacy, Department of Clinical PharmacyUniversity of Szeged, Szikra u. 8.SzegedHungary
  2. 2.Faculty of Medicine, Psychiatric DepartmentUniversity of Szeged, Szikra u. 8.SzegedHungary

Personalised recommendations